Concourse Financial Group Securities, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 940 shares of AMPH stock, worth $45,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
940
Previous 892
5.38%
Holding current value
$45,138
Previous $39,000
5.13%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$128 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$93.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.2 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$77.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.35B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...